Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports

Refractory Kawasaki disease (KD) is related to a major risk of coronary arteries abnormalities and its treatment is not standardized. In this regard, anakinra (ANA), an interleukin (IL)-1 receptor antagonist, represents an emerging therapeutic option. We report two cases of children, diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastrolia, Maria Vincenza, Abbati, Giulia, Signorino, Claudia, Maccora, Ilaria, Marrani, Edoardo, Pagnini, Ilaria, Simonini, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010843/
https://www.ncbi.nlm.nih.gov/pubmed/33854568
http://dx.doi.org/10.1177/1759720X211002593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010843/
https://www.ncbi.nlm.nih.gov/pubmed/33854568
http://dx.doi.org/10.1177/1759720X211002593

Ejemplares similares